Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Frequency Therapeutics, Inc. Common Stock (FREQ)
Pharmaceutical Preparations
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.
75 HAYDEN AVENUE, SUITE 300
LEXINGTON, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
10/03/2019
Market Cap
10,941,632
Shares Outstanding
36,520,000
Weighted SO
36,520,750
Total Employees
N/A
Upcoming Earnings
N/A
Beta
0.7710
Last Div
0.0000
Range
0.183-5.59
Chg
0.0136
Avg Vol
135075
Mkt Cap
10941632
Exch
NASDAQ
Country
US
Phone
781 315 4600
DCF Diff
-0.8450
DCF
1.1446
Div Yield
0.0000
P/S
0.0000
EV Multiple
0.5040
P/FV
0.3011
Div Yield %
0.0000
P/E
-0.1865
PEG
-0.0329
Payout
0.0000
Current Ratio
4.4216
Quick Ratio
4.3407
Cash Ratio
4.3407
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
-0.0005
ROA
-1.2797
ROE
1.8790
ROCE
-1.7204
NI/EBT
1.0005
EBT/EBIT
0.9380
EBIT/Rev
0.0000
Debt Ratio
0.0308
D/E
0.0388
LT Debt/Cap
0.0000
Total Debt/Cap
0.0374
Int Coverage
-106.0453
CF/Debt
-26.4772
Equity Multi
1.2616
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-1.0233
FCF/Share
-1.0256
Cash/Share
1.1300
OCF/Sales
0.0000
FCF/OCF
1.0022
CF Coverage
-26.4772
ST Coverage
-26.4772
CapEx Coverage
-449.7976
Div&CapEx Cov
-449.7976
P/BV
0.3011
P/B
0.3011
P/S
0.0000
P/E
-0.1865
P/FCF
-0.2889
P/OCF
-0.2928
P/CF
-0.2928
PEG
-0.0329
P/S
0.0000
EV Multiple
0.5040
P/FV
0.3011
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
2018 | 2020 | 2021 | 2022 | 2023 | 2023 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | X | ▲ XXXXXXX | ▲ XXXXXXX | ▼ X | X | 0.00 | |
Cost Of Revenue | X | X | X | X | X | 0.00 | |
Gross Profit | X | ▲ XXXXXXX | ▲ XXXXXXX | ▼ X | X | 0.00 | |
Gross Profit Ratio | X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | ▼ |
Research And Development Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 2.56M | ▼ |
General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ 10.11M | ▼ |
Selling And Marketing Expenses | X | X | X | X | X | 0.00 | |
Selling General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ 10.11M | ▼ |
Other Expenses | X | X | X | ▼ -XXXXX | ▲ XXXXXX | ▼ 0.00 | |
Operating Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 12.67M | ▼ |
Cost And Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 12.67M | ▼ |
Interest Income | X | ▲ XXXXXX | ▼ XXXXX | ▲ XXXXX | ▲ XXXXXX | ▼ 448.00K | ▼ |
Interest Expense | XXXXX | ▼ X | X | ▲ XXXXXX | ▲ XXXXXX | ▼ 0.00 | |
Depreciation And Amortization | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ 0.00 | |
Ebitda | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -12.67M | ▼ |
Ebitda Ratio | X.XXXXXXXXXX | ▼ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | ▼ |
Operating Income | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -12.67M | ▼ |
Operating Income Ratio | X.XXXXXXXXX | ▼ -X.XXXXXXXXX | ▲ -X.XXXXXXXXX | ▲ X.XXXXXXXXX | X.XXXXXXXXX | 0.00 | ▼ |
Total Other Income Expenses Net | -XXXXXX | ▲ XXXXX | ▼ -XXXXX | ▼ -XXXXX | ▲ XXXXXX | ▲ 1.04M | ▼ |
Income Before Tax | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -11.62M | ▼ |
Income Before Tax Ratio | X.XXXXXXXXXX | ▼ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | ▼ |
Income Tax Expense | XXXXX | ▼ -XXXXXXX | ▲ -XXXXX | ▲ XXXX | ▲ XXXX | ▼ -7.00K | ▼ |
Net Income | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -11.61M | ▼ |
Net Income Ratio | X.XXXXXXXXXX | ▼ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | ▼ |
Eps | -X.XX | ▲ -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▲ -0.31 | ▼ |
Eps Diluted | -X.XX | ▲ -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▲ -0.31 | ▼ |
Weighted Average Shs Out | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 36.92M | ▼ |
Weighted Average Shs Out Dil | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 36.92M | ▼ |